LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Blaze Bioscience Inc.
Headquarters:
Seattle, WA, United States
Website:
http://www.blazebioscience.com...
Year Founded:
2010
Status:
Private
BioCentury
|
May 20, 2022
Discovery & Translation
Precision’s chronic HBV gene therapy; plus Blaze and ASGCT highlights
BioCentury’s roundup of translational news
Read More
BioCentury
|
Mar 7, 2020
Translation in Brief
Repurposing a protease inhibitor for COVID-19; plus City of Hope’s scorpion venom CAR T and Blaze’s tech for tissue-targeted steroid delivery
BioCentury’s roundup of preclinical news
Read More
BioCentury
|
Sep 12, 2016
Strategy
Dealing Denali
Swarm of deals add pipeline and yield clues to Denali's CNS playbook
Read More
BioCentury
|
Sep 5, 2016
Company News
Blaze Bioscience, Denali Therapeutics deal
Read More
BioCentury
|
Aug 25, 2016
Top Story
Denali unveils $130M funding, series of deals
Read More
BioCentury
|
Dec 14, 2015
Company News
Eisai, Blaze Bioscience deal
Read More
BioCentury
|
Sep 28, 2015
Clinical News
BLZ-100: Phase I started
Read More
BioCentury
|
Jul 20, 2015
Clinical News
BLZ-100: Phase I started
Read More
BioCentury
|
Jun 22, 2015
Clinical News
BLZ-100: Phase I started
Read More
BioCentury
|
Oct 20, 2014
Clinical News
BLZ-100: Phase Ib started
Read More
Items per page:
10
1 - 10 of 18
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help